TY - JOUR
T1 - Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells
AU - Chen, Shuming
AU - Ishii, Naoto
AU - Ine, Shouji
AU - Ikeda, Syuichi
AU - Fujimura, Taku
AU - Ndhlovu, Lishomwa C.
AU - Soroosh, Pejman
AU - Tada, Kohtaro
AU - Harigae, Hideo
AU - Kameoka, Junichi
AU - Kasai, Noriyuki
AU - Sasaki, Takeshi
AU - Sugamura, Kazuo
N1 - Funding Information:
This work was supported in part by a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant-in-aid for scientific research on priority areas from the Japan Society for the Promotion of Science.
PY - 2006/2
Y1 - 2006/2
N2 - Adult T cell leukemia (ATL) is an aggressive neoplastic disease, in which a quarter of the patients develop opportunistic infections due to cellular immunodeficiency. However, the underlying mechanism responsible for the immunosuppression has remained unclear. Recent studies have demonstrated that the leukemia cells from a subset of patients with ATL express Foxp3, a specific marker for CD25+CD4+ regulatory T (Treg) cells, which regulate the immune response by suppressing CD4+ T cell functions. However, whether there is a functional resemblance between ATL cells that have Foxp3 expression and Treg cells is still unknown. In this report, we confirmed the high expression of Foxp3 in leukemia cells from 5 of 12 ATL patients and demonstrated that ATL cells from 3 patients suppressed the proliferation of CD4+ T cells. Similarly, one of six HTLV-I-infected cell lines showed both high Foxp3 expression and suppressive activity. Like Treg cells, the suppression induced by the ATL cells from two patients and the HTLV-infected cell line appeared to be mediated by a cell-cell contact-dependent mechanism. Nevertheless, among the ATL cells that strongly expressed Foxp3, those from two of the five patients showed no apparent suppressive activity. Furthermore, retroviral transfection of Foxp3 did not confer any suppressive function on low Foxp3-expressing HTLV-I-infected cell lines. These results indicate that Foxp3 may be essential but is not sufficient for the Treg-cell-like suppressive activity of ATL cells and HTLV-I-infected cell lines.
AB - Adult T cell leukemia (ATL) is an aggressive neoplastic disease, in which a quarter of the patients develop opportunistic infections due to cellular immunodeficiency. However, the underlying mechanism responsible for the immunosuppression has remained unclear. Recent studies have demonstrated that the leukemia cells from a subset of patients with ATL express Foxp3, a specific marker for CD25+CD4+ regulatory T (Treg) cells, which regulate the immune response by suppressing CD4+ T cell functions. However, whether there is a functional resemblance between ATL cells that have Foxp3 expression and Treg cells is still unknown. In this report, we confirmed the high expression of Foxp3 in leukemia cells from 5 of 12 ATL patients and demonstrated that ATL cells from 3 patients suppressed the proliferation of CD4+ T cells. Similarly, one of six HTLV-I-infected cell lines showed both high Foxp3 expression and suppressive activity. Like Treg cells, the suppression induced by the ATL cells from two patients and the HTLV-infected cell line appeared to be mediated by a cell-cell contact-dependent mechanism. Nevertheless, among the ATL cells that strongly expressed Foxp3, those from two of the five patients showed no apparent suppressive activity. Furthermore, retroviral transfection of Foxp3 did not confer any suppressive function on low Foxp3-expressing HTLV-I-infected cell lines. These results indicate that Foxp3 may be essential but is not sufficient for the Treg-cell-like suppressive activity of ATL cells and HTLV-I-infected cell lines.
KW - ATL
KW - Foxp3
KW - HTLV-1
KW - Regulatory T cell
UR - http://www.scopus.com/inward/record.url?scp=31544442501&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=31544442501&partnerID=8YFLogxK
U2 - 10.1093/intimm/dxh366
DO - 10.1093/intimm/dxh366
M3 - Article
C2 - 16361311
AN - SCOPUS:31544442501
SN - 0953-8178
VL - 18
SP - 269
EP - 277
JO - International Immunology
JF - International Immunology
IS - 2
ER -